Correlation Between SINOPHARM GROUP and Prestige Consumer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SINOPHARM GROUP and Prestige Consumer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SINOPHARM GROUP and Prestige Consumer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SINOPHARM GROUP 15ON and Prestige Consumer Healthcare, you can compare the effects of market volatilities on SINOPHARM GROUP and Prestige Consumer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SINOPHARM GROUP with a short position of Prestige Consumer. Check out your portfolio center. Please also check ongoing floating volatility patterns of SINOPHARM GROUP and Prestige Consumer.

Diversification Opportunities for SINOPHARM GROUP and Prestige Consumer

0.34
  Correlation Coefficient

Weak diversification

The 3 months correlation between SINOPHARM and Prestige is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding SINOPHARM GROUP 15ON and Prestige Consumer Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prestige Consumer and SINOPHARM GROUP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SINOPHARM GROUP 15ON are associated (or correlated) with Prestige Consumer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prestige Consumer has no effect on the direction of SINOPHARM GROUP i.e., SINOPHARM GROUP and Prestige Consumer go up and down completely randomly.

Pair Corralation between SINOPHARM GROUP and Prestige Consumer

Assuming the 90 days trading horizon SINOPHARM GROUP is expected to generate 2.01 times less return on investment than Prestige Consumer. But when comparing it to its historical volatility, SINOPHARM GROUP 15ON is 1.02 times less risky than Prestige Consumer. It trades about 0.18 of its potential returns per unit of risk. Prestige Consumer Healthcare is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest  6,700  in Prestige Consumer Healthcare on September 3, 2024 and sell it today you would earn a total of  1,150  from holding Prestige Consumer Healthcare or generate 17.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

SINOPHARM GROUP 15ON  vs.  Prestige Consumer Healthcare

 Performance 
       Timeline  
SINOPHARM GROUP 15ON 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SINOPHARM GROUP 15ON are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, SINOPHARM GROUP reported solid returns over the last few months and may actually be approaching a breakup point.
Prestige Consumer 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Prestige Consumer Healthcare are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Prestige Consumer reported solid returns over the last few months and may actually be approaching a breakup point.

SINOPHARM GROUP and Prestige Consumer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SINOPHARM GROUP and Prestige Consumer

The main advantage of trading using opposite SINOPHARM GROUP and Prestige Consumer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SINOPHARM GROUP position performs unexpectedly, Prestige Consumer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prestige Consumer will offset losses from the drop in Prestige Consumer's long position.
The idea behind SINOPHARM GROUP 15ON and Prestige Consumer Healthcare pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing